Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

TB-500 Dosage Hair Growth 2026: Protocol Comparison

Seoul National (2023) 2.5mg subcutaneous Twice weekly 5mg 16 weeks 18% increase in anagen follicle density vs baseline Gold standard. Twice-weekly dosing maintains stable Wnt signaling without systemic saturation UPenn Follicle Lab (2021) 2mg subcutaneous Once

This comparison does not assign a generated winner or score.

  • Seoul National (2023)
  • 2.5mg subcutaneous
  • Twice weekly
  • 5mg
  • 16 weeks
  • 18% increase in anagen follicle density vs baseline
  • Gold standard. Twice-weekly dosing maintains stable Wnt signaling without systemic saturation
  • UPenn Follicle Lab (2021)
  • 2mg subcutaneous
  • Once weekly
  • 2mg
  • 12 weeks
  • Anagen extension by 12 days (measured via phototrichogram)
  • Effective but near-threshold. Response plateaus without dose escalation
  • Modified High-Dose (observational)
  • 5mg subcutaneous
  • 10mg
  • No additional follicle density gain vs 5mg/week; increased joint discomfort reports
  • Exceeds receptor saturation. Systemic exposure without proportional benefit
  • Maintenance Protocol (theoretical)
  • Ongoing after initial 16-week induction
  • Hypothesised to sustain gains from induction phase
  • Not yet validated in published studies. Maintenance dosing remains experimental
More references

Related material